Xu Zhenyu Insider Trading Activity
Xu Zhenyu has been net-selling over the last 12 months with 0 purchases and 19 sales across 1 company.
SOPH is the most-traded position with 19 trades. The largest single transaction was a sale of SOPH for $89K on Aug 27, 2026.
Performance Scorecard
Forward stock performance after each transaction by Xu Zhenyu. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -8.0% | 25% | 16 |
| 90 days | — | -24.4% | 0% | 12 |
| 120 days | — | -47.6% | 0% | 10 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersSOPH · SOPHiA GENETICS SA
🔒 Subscribe to see trade entries
Pro members see exactly when Xu Zhenyu bought and sold SOPH.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Aug 27, 2026 | SOPH | Sell | 10,000 | $8.91 | $89K | −1.8% | Chief Scientific Officer | |
Aug 7, 2026 | SOPH | Sell | 10,000 | $7.48 | $75K | −1.7% | Chief Scientific Officer | |
Aug 7, 2026 | SOPH | Sell | 7,000 | $7.02 | $49K | −1.2% | Chief Scientific Officer | |
Aug 5, 2026 | SOPH | Sell | 3,000 | $7.00 | $21K | −0.5% | Chief Scientific Officer | |
Aug 4, 2026 | SOPH | Sell | 10,000 | $6.92 | $69K | −1.6% | Chief Scientific Officer | |
Jul 13, 2026 | SOPH | Sell | 4,000 | $5.70 | $23K | −0.7% | Chief Scientific Officer | |
Jul 6, 2026 | SOPH | Sell | 7,393 | $5.17 | $38K | −1.2% | Chief Scientific Officer | |
May 19, 2026 | SOPH | Sell | 608 | $4.60 | $3K | −0.1% | Chief Scientific Officer | |
May 13, 2026 | SOPH | Sell | 4,000 | $4.54 | $18K | −0.6% | Chief Scientific Officer | |
Apr 20, 2026 | SOPH | Sell | 608 | $5.21 | $3K | −0.1% | Chief Scientific Officer | |
Apr 14, 2026 | SOPH | Sell | 600 | $4.97 | $3K | −0.1% | Chief Scientific Officer | |
Apr 13, 2026 | SOPH | Sell | 3,400 | $4.76 | $16K | −0.5% | Chief Scientific Officer | |
Apr 13, 2026 | SOPH | Sell | 1,014 | $4.76 | $5K | −0.2% | Chief Scientific Officer | |
Apr 10, 2026 | SOPH | Sell | 3,706 | $4.68 | $17K | −0.6% | Chief Scientific Officer | |
Apr 9, 2026 | SOPH | Sell | 1,936 | $4.74 | $9K | −0.3% | Chief Scientific Officer | |
Apr 8, 2026 | SOPH | Sell | 2,800 | $4.84 | $14K | −0.4% | Chief Scientific Officer | |
Apr 7, 2026 | SOPH | Sell | 2,400 | $4.87 | $12K | −0.4% | Chief Scientific Officer | |
Apr 6, 2026 | SOPH | Sell | 2,700 | $4.85 | $13K | −0.4% | Chief Scientific Officer | |
Mar 19, 2026 | SOPH | Sell | 608 | $4.78 | $3K | −0.1% | Chief Scientific Officer |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| SOPH | SOPHiA GENETICS SA | 19 | $480K |
Other insiders at SOPHiA GENETICS SA
8 other tracked filers at SOPH.